Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

42.16
Delayed Data
As of Feb 24
 -0.17 / -0.40%
Today’s Change
33.60
Today|||52-Week Range
50.40
+10.51%
Year-to-Date
Mylan (MYL) to Post Q4 Earnings: Will the Stock Disappoint?
Feb 24 / Zacks.com - Paid Partner Content
Where Are the Best Buying Opportunities in Stocks Right Now?
Feb 21 / Zacks.com - Paid Partner Content
Fore Research & Management, LP Buys CA, Vodafone Group PLC, LiLAC Group, Sells Centra...
Feb 23 / GuruFocus News - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 22 / GuruFocus News - Paid Partner Content
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Feb 16 / MotleyFool.com - Paid Partner Content
Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat
Feb 22 / MotleyFool.com - Paid Partner Content
Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
Feb 14 / Zacks.com - Paid Partner Content
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content